Accompanying the rising pool of aging of populations worldwide, and increased survival with chronic diseases, the incidence, and prevalence of atrial fibrillation (AF) are rising, which has emerged synonymous with the global epidemic.
Intertwined with common concomitant cardiovascular diseases, which multifactorial arrhythmia shares classical cardiovascular risk factors like hypertension, hyperlipidemia, among others.
Thus, the aforementioned is responsible to contribute to the growth of the global cardiac mapping market during the forecast period which the Knowledge Sourcing Intelligence is projected to grow at a CAGR of 9.46% to attain a market size of US$1,527.102 million by 2025 from the market value of US$887.841 million estimated for 2019.
The text above is a summary, Originally published at visit here.
